Gary Gamboa received a Bachelor's of Science degree in Microbiology from Indiana University. Gary started his career in several molecular biology research positions at Riley Research Hospital in Indianapolis and Monsanto in St. Louis. He joined Lilly in 1986 as a biologist, continuing to perform molecular biology experimentation. In 1990, he joined the Parenteral Products Manufacturing Division where he has served the last 23 years in various Technical Services/Manufacturing Science roles. While at Lilly, Gary has influenced and developed strategies for the execution of new product commercialization, technology transfer, control strategy, and process validation. Gary has executed, led, and advised numerous drug product process validation exercises and technology transfers, including global transfers of products within Lilly and to contract manufacturers. His most recent assignments have focused on commercialization activities of new parenteral bio-molecule drug products, including oversight of their process validation.